Dr Sally Rayment argues that stigma around botulinum toxin needs to be challenged to ensure equitable access Botulinum toxin has revolutionised both aesthetic and medical practices. Nonetheless, it remains entangled in a web of negative societal perceptions around gender norms, …
Subscriber content
Continue reading this clinical article
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
